NCI | Technology Transfer

IDENTIFICATION OF SEQUENCE VARIANTS OF THE ERVMER34-1 SEQUENCE
FAMILY AND USE IN ANTI-CANCER THERAPIES

Read more about IDENTIFICATION OF SEQUENCE VARIANTS OF THE ERVMER34-1 SEQUENCE FAMILY AND USE IN ANTI-CANCER THERAPIES

US Application 19/502,979
Filed on 2026-01-16

IDENTIFICATION OF SEQUENCE VARIANTS OF THE ERVMER34-1 SEQUENCE FAMILY AND USE IN ANTI-CANCER THERAPIES

Read more about IDENTIFICATION OF SEQUENCE VARIANTS OF THE ERVMER34-1 SEQUENCE FAMILY AND USE IN ANTI-CANCER THERAPIES

Australia
2024296108
Filed on 2026-02-09

IDENTIFICATION OF SEQUENCE VARIANTS OF THE ERVMER34-1 SEQUENCE FAMILY AND USE IN ANTI-CANCER THERAPIES

Read more about IDENTIFICATION OF SEQUENCE VARIANTS OF THE ERVMER34-1 SEQUENCE FAMILY AND USE IN ANTI-CANCER THERAPIES

Canada
3298848
Filed on 2026-01-15

KINASE INHIBITORS

Read more about KINASE INHIBITORS

US Application 19/502,510
Filed on 2026-01-15

HUMANIZED 40H3 ANTIBODY

Read more about HUMANIZED 40H3 ANTIBODY

European Patent
24748511.3
Filed on 2026-01-27

HUMANIZED 40H3 ANTIBODY

Read more about HUMANIZED 40H3 ANTIBODY

US Application 19/497,173
Filed on 2025-12-24

HUMANIZED 40H3 ANTIBODY

Read more about HUMANIZED 40H3 ANTIBODY

Australia
2024296940
Filed on 2026-01-13

HUMANIZED 40H3 ANTIBODY

Read more about HUMANIZED 40H3 ANTIBODY

Canada
3297257
Filed on 2025-12-30

HUMANIZED 40H3 ANTIBODY

Read more about HUMANIZED 40H3 ANTIBODY

Japan
2026-500043
Filed on 2026-01-05

EPIDITHIODIKETOPIPERAZINE ANALOGS AND METHODS OF USE

Read more about EPIDITHIODIKETOPIPERAZINE ANALOGS AND METHODS OF USE

US Application 19/492,894
Filed on 2025-12-12

Subscribe to NCI